HPMCs treated with TNFalpha and IL-17A

ABSTRACT: Human mesothelial peritoneal cells from high grade serous ovarian carcinoma patients were subjected to TNFalpha, IL17-A and combination treatment.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Florian Finkernagel 

PROVIDER: E-MTAB-13497 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress